Imiglucerase
Systematic (IUPAC) name | |
---|---|
Human Beta-glucocerebrosidase
|
|
Clinical data | |
AHFS/Drugs.com | monograph |
MedlinePlus | a601149 |
Licence data | EMA:Link, US FDA:link |
Routes of administration |
Intravenous |
Pharmacokinetic data | |
Biological half-life | 3.6-10.4 min |
Identifiers | |
CAS Number | 143003-46-7 ![]() |
ATC code | A16AB02 (WHO) |
DrugBank | DB00053 ![]() |
UNII | Q6U6J48BWY ![]() |
KEGG | D02810 ![]() |
ChEMBL | CHEMBL1201632 ![]() |
Chemical data | |
Formula | C2532H3854N672O711S16 |
Molecular mass | 55597.4 g/mol (unglycosylated) |
![]() ![]() |
Imiglucerase is a medication used in the treatment of Gaucher's disease.[1][2]
It is a recombinant DNA-produced analogue of human β-glucocerebrosidase. Cerezyme is a freeze-dried medicine containing imiglucerase, manufactured by Genzyme Corporation. It is given intravenously after reconstitution as a treatment for Type 1 Gaucher's disease. It is available in formulations containing 200 or 400 units per vial. The specific activity of highly purified human enzyme is 890,000 units/mg.[3] A typical dose is 2.5U/kg every two weeks, up to a maximum of 60 U/kg once every two weeks, and safety has been established from ages 2 and up.[4] It is one of the most expensive drugs sold, with an annual cost to U.S. patients of $200,000.[5] Due to the low profitability (and high expense) of developing medications for rare conditions, imiglucerase has been granted orphan drug status in the USA, Australia, and Japan.[6]
Cerezyme was one of the drugs manufactured at Genzyme's Allston, Massachusetts plant, for which production was disrupted in 2009 after contamination with Vesivirus 2117.[7]
See also
- Other drugs for the treatment of Gaucher's disease
- Afegostat (development terminated)
- Eliglustat
- Miglustat
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Balancing innovation, access, and profits -- marketing exclusivity for biologics, Alfred B. Engelberg et al., N Engl J Med 361:1917
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemicals that do not have a ChemSpider ID assigned
- Articles without InChI source
- Drugs with no legal status
- Drugs acting on the gastrointestinal system and metabolism
- Orphan drugs
- Recombinant proteins
- Gastrointestinal system drug stubs